FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models.
| Image |  |
|---|---|
| Description | scientific article published on 16 November 2017 |
| Author/s |
author: Nives Carenini Michelandrea De Cesare Emilio Ciusani Eugenio Scanziani Cristina Corno Lucia Minoli Laura Gatti Paola Perego Nadia Zaffaroni |
| Publication date | November 16, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |